2021
DOI: 10.1016/j.bioactmat.2021.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Practical strategy to construct anti-osteosarcoma bone substitutes by loading cisplatin into 3D-printed titanium alloy implants using a thermosensitive hydrogel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 61 publications
1
28
0
Order By: Relevance
“…The porous structure was designed based on a bionic trabecular structure unit cell using CAD software (10). The porous Ti 6 Al 4 V scaffold was printed with a pore size of 640 μm, filament diameter of 400 μm, and porosity of 73%, as previously described (25).…”
Section: Sample Fabricationmentioning
confidence: 99%
“…The porous structure was designed based on a bionic trabecular structure unit cell using CAD software (10). The porous Ti 6 Al 4 V scaffold was printed with a pore size of 640 μm, filament diameter of 400 μm, and porosity of 73%, as previously described (25).…”
Section: Sample Fabricationmentioning
confidence: 99%
“…In the study of Jing et al, a PLGA-polyethylene glycol-PLGA temperature-sensitive hydrogel was used for the stable storage of cisplatin. The local temperature of the implant can be used as a “switch” for the release of cisplatin, as schematically represented in Figure 4 D. The results of experiments in a rat tumor model show that the implants of the experimental group had better anti-osteosarcoma effects and fewer side effects, and also had a positive effect on osteogenesis [ 76 ]. However, the simple hydrogel covering the surface of the titanium implants may have the problem of unstable bonding and easily slipping off after being exposed to external force.…”
Section: Antitumor Effectsmentioning
confidence: 99%
“…( C ) The experimental scheme of Zhang et al; reprinted with permission from [ 74 ]; copyright 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ( D ) The experimental scheme of Jing et al; reprinted with permission from [ 76 ]; copyright 2021 Zehao Jing et al ( E ) Images of tumors collected from tumor-bearing mice after various treatments; reprinted with permission from [ 74 ]; copyright 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ( F ) The experimental scheme of Sarkar et al; reprinted with permission from [ 77 ]; copyright 2020 American Chemical Society.…”
Section: Figurementioning
confidence: 99%
“…A total of 24 articles [ [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] ] are included in this special issue. These articles can be categorized in terms of authors, biomaterials and targeted clinical areas, and article types.…”
mentioning
confidence: 99%
“…Several articles in this special issue are on regulatory science and discuss the new standards, tools, and approaches to evaluate the safety, efficacy, quality, and performance of medical products [ 10 , 13 , 17 , 19 ]. This special issue also covers a wide range of article types including research article [ [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , 11 , 12 , 15 , 16 , [18] , [19] , [20] , [23] , [24] , [25] , [26] ], reviews [ 14 , 17 , 21 , 22 , 27 ], perspectives [ 10 , 13 ] and opinion paper [ 18 ].…”
mentioning
confidence: 99%